SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001140361-23-045410
Filing Date
2023-09-27
Accepted
2023-09-27 08:12:13
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A ef20011271_scto-ta.htm SC TO-T/A 22055
2 EXHIBIT 99.(A)(5)(B) ef20011271_ex99-a5b.htm EX-99.(A)(5)(B) 9557
3 image00001.jpg GRAPHIC 7868
  Complete submission text file 0001140361-23-045410.txt   44307
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Subject) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-88971 | Film No.: 231281863
SIC: 2834 Pharmaceutical Preparations

Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filed by) CIK: 0001802665 (see all company filings)

IRS No.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2834 Pharmaceutical Preparations